Literature DB >> 23730563

Correlation between lipid profile and troponin I test results in patients with chest pain in Nepal.

Arun Kumar1, Brijesh Sathian.   

Abstract

OBJECTIVE: To study the usefulness of traditional lipid profile levels in screening subjects who had developed chest pain due to cardiac event as indicated by a positive troponin I test.
METHODS: In this retrospective study data of the 430 patients presented to the emergency department with symptoms of cardiac ischemia who underwent both troponin and lipid profiles tests were compared with the lipid profiles of 165 normal healthy subjects (controls). The troponin was detected qualitatively when a specimen contains troponin I (cTnI) above the 99th percentile (TnI>0.5 ng/mL). The total cholesterol, high density lipoproteins cholesterol, very low density lipoproteins and triacyl glycerol levels were also analyzed and low density lipoprotein level was calculated using Friedewald's formula.
RESULTS: Patients with chest pain and positive troponin test (with confirmed cardiac event) were found to have significantly elevated levels of total cholesterol, triacyl glycerol levels, low density lipoprotein level and significantly reduced high density lipoproteins cholesterol levels when compared to the patients who experienced only chest pain (negative troponin) and healthy controls.
CONCLUSIONS: Traditional lipid profile levels is still can be used in screening populations to identify the subjects with high risk of developing cardiac event in case if the laboratory set up has not troponin test facilities.

Entities:  

Keywords:  Cardiac event; Chest pain; Lipid profile; Nepal; Troponin

Mesh:

Substances:

Year:  2013        PMID: 23730563      PMCID: PMC3644578          DOI: 10.1016/S2221-1691(13)60101-X

Source DB:  PubMed          Journal:  Asian Pac J Trop Biomed        ISSN: 2221-1691


  11 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  High-sensitivity cardiac troponin assays: what analytical and clinical issues need to be addressed before introduction into clinical practice? Interview by Fred S. Apple.

Authors:  Alan Wu; Paul Collinson; Allan Jaffe; David Morrow
Journal:  Clin Chem       Date:  2010-04-08       Impact factor: 8.327

3.  Will the real myocardial infarction please stand up?

Authors:  Joseph S Alpert
Journal:  Clin Chem       Date:  2006-05       Impact factor: 8.327

Review 4.  2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Elliott M Antman; Mary Hand; Paul W Armstrong; Eric R Bates; Lee A Green; Lakshmi K Halasyamani; Judith S Hochman; Harlan M Krumholz; Gervasio A Lamas; Charles J Mullany; David L Pearle; Michael A Sloan; Sidney C Smith; Daniel T Anbe; Frederick G Kushner; Joseph P Ornato; David L Pearle; Michael A Sloan; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Christopher E Buller; Mark A Creager; Steven M Ettinger; Jonathan L Halperin; Sharon A Hunt; Bruce W Lytle; Rick Nishimura; Richard L Page; Barbara Riegel; Lynn G Tarkington; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2008-01-15       Impact factor: 24.094

5.  Sensitive troponin I assay in patients with suspected acute coronary syndrome.

Authors:  Allan S Jaffe; Bertil Lindahl; Hugo A Katus
Journal:  JAMA       Date:  2011-08-03       Impact factor: 56.272

6.  Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I.

Authors:  Marc Bonaca; Benjamin Scirica; Marc Sabatine; Anthony Dalby; Jindrich Spinar; Sabina A Murphy; Peter Jarolim; Eugene Braunwald; David A Morrow
Journal:  J Am Coll Cardiol       Date:  2010-05-11       Impact factor: 24.094

7.  Letter by Lippi and Cervellin regarding article, "High-sensitivity troponin T concentrations in acute chest pain patients evaluated with cardiac computed tomography".

Authors:  Giuseppe Lippi; Gianfranco Cervellin
Journal:  Circulation       Date:  2011-01-04       Impact factor: 29.690

8.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

9.  Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome.

Authors:  Nicholas L Mills; Antonia M D Churchhouse; Kuan Ken Lee; Atul Anand; David Gamble; Anoop S V Shah; Elspeth Paterson; Margaret MacLeod; Catriona Graham; Simon Walker; Martin A Denvir; Keith A A Fox; David E Newby
Journal:  JAMA       Date:  2011-03-23       Impact factor: 56.272

10.  Assessing the requirement for the 6-hour interval between specimens in the American Heart Association Classification of Myocardial Infarction in Epidemiology and Clinical Research Studies.

Authors:  Andrew R Macrae; Peter A Kavsak; Viliam Lustig; Rakesh Bhargava; Rudy Vandersluis; Glenn E Palomaki; Marie-Jeanne Yerna; Allan S Jaffe
Journal:  Clin Chem       Date:  2006-03-23       Impact factor: 8.327

View more
  2 in total

1.  High-density lipoprotein cholesterol values independently and inversely predict cardiac troponin T and I concentration.

Authors:  Giuseppe Lippi; Claudia Lo Cascio; Giorgio Brocco; Elisa Danese; Martina Montagnana; Antonella Bassi; Beatrice Caruso; Chiara Bovo; Gian Luca Salvagno
Journal:  Ann Transl Med       Date:  2016-05

2.  Relationship of Lipid Profile and Serum Ferritin levels with Acute Myocardial Infarction.

Authors:  Bharat Kumar Gupta; Ranjan Solanki; Himanshu Punia; Vibhuti Agarwal; Jaskiran Kaur; Ashish Shukla
Journal:  J Clin Diagn Res       Date:  2014-08-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.